Atlassian Corporation (NASDAQ: TEAM): Is It A Buying Opportunity Again?

After Hours

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Stocks Info

Atlassian Corporation is listed on the NASDAQ as a member of the Technology sector and is a part of the Software – Application industry. The current market capitalization of Atlassian Corporation is $50.55B. A total of 2.38 million shares were traded on the day, compared to an average of 1.76M shares.

In the most recent transaction, Cannon-Brookes Michael sold 8,241 shares of TEAM for 197.46 per share on Apr 15 ’24. After the transaction, the Co-CEO, Co-Founder now owns 424,137 company shares. In a previous transaction on Apr 15 ’24, Farquhar Scott sold 8,241 shares at 197.46 per share. TEAM shares that Co-CEO, Co-Founder owns now total 424,137.

Among the insiders who sold shares, Cannon-Brookes Michael disposed of 8,241 shares on Apr 12 ’24 at a per-share price of $207.36. This resulted in the Co-CEO, Co-Founder holding 432,378 shares of TEAM after the transaction. In another insider transaction, Farquhar Scott sold 8,241 shares at $207.36 per share on Apr 12 ’24. Company shares held by the Co-CEO, Co-Founder now total 432,378.

Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, TEAM has a high of $258.69 and a low of $128.02.

As of this writing, TEAM has an earnings estimate of $Beam Therapeutics Inc. per share for the current quarter. EPS was calculated based on a consensus of Atlassian Corporation estimates, with a high estimate of $5E Advanced Materials, Inc. per share and a lower estimate of $Team, Inc..

Balance Sheet Annually/Quarterly

A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. TEAM’s latest balance sheet shows that the firm has $1.46B in Cash & Short Term Investments as of fiscal 2022. There were $1.31B in debt and $1.59B in liabilities at the time. Its Book Value Per Share was $3.49, while its Total Shareholder’s Equity was $327.37M.

Analysts Opinion

It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for TEAM is Buy with a score of 3.96.

Most Popular

Related Posts